Zobrazeno 1 - 10
of 2 035
pro vyhledávání: '"Lung and Intrathoracic Tumors"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel Danis, Julius O. B. Jacobsen, Alex H. Wagner, Tudor Groza, Martha A. Beckwith, Lauren Rekerle, Leigh C. Carmody, Justin Reese, Harshad Hegde, Markus S. Ladewig, Berthold Seitz, Monica Munoz-Torres, Nomi L. Harris, Jordi Rambla, Michael Baudis, Christopher J. Mungall, Melissa A. Haendel, Peter N. Robinson
Publikováno v:
PloS one, vol 18, iss 5
The Global Alliance for Genomics and Health (GA4GH) is a standards-setting organization that is developing a suite of coordinated standards for genomics. The GA4GH Phenopacket Schema is a standard for sharing disease and phenotype information that ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea118208482336ee8d1c009bb9467e0
https://escholarship.org/uc/item/2vm8j4cj
https://escholarship.org/uc/item/2vm8j4cj
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Yuki Ono, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Isamu Okamoto, Masaki Mori
Publikováno v:
PLoS ONE
PLoS ONE, Vol 17, Iss 2, p e0263247 (2022)
PLoS ONE, Vol 17, Iss 2, p e0263247 (2022)
A recent study suggested that proton pump inhibitor (PPI) use in patients with advanced non-small-cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICIs) was associated with poor clinical outcomes. However, the clinical impact of PPI u
Autor:
Karadzovska-Kotevska, Marija, Brunnström, Hans, Kosieradzki, Jaroslaw, Ek, Lars, Estberg, Christel, Staaf, Johan, Barath, Stefan, Planck, Maria
Publikováno v:
PLoS ONE
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive bronchoscopic procedure, well established as a diagnostic modality of first choice for diagnosis and staging of non-small cell lung cancer (NSCLC). T
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE, Vol 17, Iss 1, p e0263292 (2022)
PLoS ONE
PLoS ONE, Vol 17, Iss 1, p e0263292 (2022)
PLoS ONE
Objectives We aimed to explore the synergistic combination of a topologically invariant Betti number (BN)-based signature and a biomarker for the accurate prediction of symptomatic (grade ≥2) radiation-induced pneumonitis (RP+) before stereotactic
Autor:
Yong Du, Angel Cortez, Anders Josefsson, Mohammadreza Zarisfi, Rebecca Krimins, Eleni Liapi, Jessie R. Nedrow
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE
PLoS ONE, Vol 17, Iss 1, p e0261982 (2022)
PLoS ONE
PLoS ONE, Vol 17, Iss 1, p e0261982 (2022)
Hepatocellular carcinoma is the most common primary liver cancer and the fifth most frequently diagnosed cancer worldwide. Most patients with advanced disease are offered non-surgical palliative treatment options. This work explores the first alpha-p
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263629 (2022)
PLoS ONE
PLoS ONE
Background Immunotherapy has emerged as a promising treatment for non-small cell lung cancer (NSCLC). Yet, some patients cannot benefit from immunotherapy, and reliable biomarkers for selecting sensitive patients are needed. Herein, we performed a me
Autor:
Burcu Ayhan-Sahin, Zeynep-Elif Apaydın, Pınar Obakan-Yerlikaya, Elif-Damla Arisan, Ajda Coker-Gurkan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 17, Iss 1, p e0260144 (2022)
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE, Vol 17, Iss 1, p e0260144 (2022)
PLoS ONE, Vol 17, Iss 1 (2022)
Background Growth Hormone Releasing Hormone (GHRH), 44 amino acids containing hypothalamic hormone, retains the biological activity by its first 29 amino acids. GHRH (NH2 1–29) peptide antagonists inhibit the growth of prostate, breast, ovarian, re